Suggested Topics within your search.
Suggested Topics within your search.
Oratorios
52
Oratorios (Música)
32
Música vocal sacra
16
Songs and music
15
Música de la pasión
10
Música barroca
7
Operas
7
Christmas music
4
Motetes
4
Musical settings
4
Passion music
4
Concerti grossi
3
Misa (Música)
3
Música de navidad
3
Ave María (Música)
2
Ballets
2
Bibliografía
2
Canciones y música
2
Cantatas sacras
2
Choruses, Sacred (Mixed voices) with instrumental ensemble
2
Coros sacros (Voces mixtas) con orquesta
2
Excerpts
2
Extractos
2
Historia
2
Música Vocal Sacra
2
Música orquestal
2
Música vocal
2
Oratorios (música)
2
Seasons
2
String orchestra music
2
-
1by Bach, Johann Sebastian, 1685-1750Subjects: “…Oratorios (Música). 358549…”
Published 1992
CD Audio -
2
-
3
-
4
-
5Published 1994Table of Contents: “…Weihnachts-Oratorium = Christmas Oratorio: Bereite dich, Zion = Prepare thyself, Zion. …”
Musical Score Book -
6by Bach, Johann Sebastian, 1685-1750Subjects: “…Oratorios (música) Partituras.…”
Published 1992
Musical Score Book -
7
-
8by Le Sueur, 1760-1837Subjects: “…Oratorios (Música), Extractos.…”
Published 1993
Conference Proceeding CD Audio -
9
-
10by Wolinsky, Jerry S., Montalban, Xavier, Hauser, Stephen L., Giovannoni, Gavin, Vermersch, Patrick, Bernasconi, Corrado, Deol‐Bhullar, Gurpreet, Garren, Hideki, Chin, Peter, Belachew, Shibeshih, Kappos, Ludwig“…In the placebo‐controlled phase III ORATORIO study (NCT01194570), we investigated the effect of ocrelizumab on this comprehensive outcome and its components in a post‐hoc analysis. …”
Published 2018
Get full text
Get full text
Get full text
Online Article Text -
11Subjects: “…Oratorios Partituras.…”
Book -
12by Gibiansky, Ekaterina, Petry, Claire, Mercier, Francois, Günther, Andreas, Herman, Ann, Kappos, Ludwig, Hauser, Stephen, Yamamoto, Yumi, Wang, Qing, Model, Fabian, Kletzl, Heidemarie“…METHODS: A population pharmacokinetic model was developed based on data from the Phase II study and the Phase III studies OPERA I and OPERA II in patients with RMS. Data from the ORATORIO Phase III study in patients with PPMS became available after model finalization and was used for external model evaluation. …”
Published 2020
Get full text
Get full text
Get full text
Online Article Text -
13by Butzkueven, Helmut, Spelman, Tim, Horakova, Dana, Hughes, Stella, Solaro, Claudio, Izquierdo, Guillermo, Kubala Havrdová, Eva, Grand'Maison, Francois, Prat, Alexandre, Girard, Marc, Hupperts, Raymond, Onofrj, Marco, Lugaresi, Alessandra, Taylor, Bruce, Giovannoni, Gavin, Kappos, Ludwig, Hauser, Stephen L., Montalban, Xavier, Craveiro, Licinio, Freitas, Rita, Model, Fabian, Overell, James, Muros‐Le Rouzic, Erwan, Sauter, Annette, Wang, Qing, Wormser, David, Wolinsky, Jerry S.“…METHODS: Post hoc analyses assessing time to 24‐week confirmed EDSS ≥7.0 in two cohorts of patients with primary progressive multiple sclerosis (baseline EDSS 3.0–6.5) were investigated in ORATORIO and MSBase. RESULTS: In the ORATORIO DBP+ECP, ocrelizumab reduced the risk of 24‐week confirmed EDSS ≥7.0 (hazard ratio = 0.54, 95% confidence interval [CI]: 0.31–0.92; p = 0.022). …”
Published 2021
Get full text
Get full text
Get full text
Online Article Text -
14
-
15
-
16
-
17by Fox, Edward J, Markowitz, Clyde, Applebee, Angela, Montalban, Xavier, Wolinsky, Jerry S, Belachew, Shibeshih, Fiore, Damian, Pei, Jinglan, Musch, Bruno, Giovannoni, Gavin“…OBJECTIVE: This exploratory analysis examined the effects of ocrelizumab on confirmed progression (CP) and confirmed improvement (CI) in UE impairment in patients from ORATORIO. METHODS: Patients with PPMS received ocrelizumab 600 mg or placebo every 24 weeks for ⩾120 weeks. …”
Published 2018
Get full text
Get full text
Get full text
Online Article Text -
18
-
19
-
20